Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy
Author: Hiwase, D.
White, D.
Zrim, S.
Saunders, V.
Vaz de Melo, J.
Hughes, T.
Citation: Leukemia, 2010; 24(3):658-660
Publisher: Nature Publishing Group
Issue Date: 2010
ISSN: 0887-6924
Statement of
DK Hiwase, D White, S Zrim, V Saunders, J V Melo and T P Hughes
Keywords: K562 Cells; Humans; Pyrimidines; Thiazoles; Antineoplastic Combined Chemotherapy Protocols; Protein Kinase Inhibitors; Drug Synergism; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Dasatinib; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1
RMID: 0020094369
DOI: 10.1038/leu.2009.242
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.